# A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomi

Source: https://onco.cc/trials/nct04712097/  
OnCo record `nct04712097` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Mosunetuzumab, Lenalidomide, Rituximab in follicular lymphoma, run by Hoffmann-La Roche, active and no longer recruiting.

## Summary

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma is a phase 3 interventional study registered as NCT04712097 by Hoffmann-La Roche, with 478 participants enrolled, started 2021-10-27 and due to reach its primary completion in 2026-06-03. Interventions recorded: Mosunetuzumab, Lenalidomide, Rituximab, Tociluzumab. Conditions listed: Relapsed or Refractory Follicular Lymphoma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT04712097
- Phase: 3
- Setting: Phase III Randomized, Open-Label, Multicenter Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a Non-Randomized Single Arm US Extension of Mosunetuzumab in Combination With Lenalidomide in Patients With Follicular Lymphoma After at Least One Line of Systemic Therapy
- Sponsor: Hoffmann-La Roche
- Enrolled: 478

## Sources

- ClinicalTrials.gov NCT04712097: https://clinicaltrials.gov/study/NCT04712097

## Connected records

- cancers: [Follicular lymphoma](https://onco.cc/cancers/follicular-lymphoma/)
- drugs: [Lenalidomide](https://onco.cc/drugs/lenalidomide/), [Mosunetuzumab](https://onco.cc/drugs/mosunetuzumab/), [Rituximab](https://onco.cc/drugs/rituximab/)
- companies: [Roche / Genentech](https://onco.cc/companies/roche-genentech/)

---
JSON: https://onco.cc/api/v1/entities/nct04712097.json